disease caused by severe acute respiratory syndrome coronavirus
2 that was first identified during December 2019 in Wuhan,
China.
"Department." The Department of Health of the Commonwealth.
"Program." The COVID-19 Antibody Testing Pilot Program
established under section 5752(a) (relating to establishment
and administration of program).
§ 5752. Establishment and administration of program.
(a) Establishment.--The COVID-19 Antibody Testing Pilot
Program is established within the department.
(b) Eligibility.--An employer in this Commonwealth that
submits a COVID-19 antibody testing plan and receives an
approval of the plan from the department under section 5753
(relating to COVID-19 antibody testing plan) shall be eligible
to participate in the program.
(c) Reimbursement.--An eligible employer under subsection
(b) may submit documentation detailing the expenses incurred by
the employer for COVID-19 antibody testing to the department for
a reimbursement under the program. Upon receipt of the
documentation, the department shall reimburse the employer for
the expenses incurred by the employer for COVID-19 antibody
testing from Federal funds allocated to mitigate the spread of
COVID-19 in this Commonwealth.
§ 5753. COVID-19 antibody testing plan.
(a) Submission of plan.--No later than seven days after the
effective date of this section, an employer in this Commonwealth
seeking to participate in the program shall submit a COVID-19
antibody testing plan for employees of the employer to the
Department of Health if the employer has been subject to closure
as a result of the COVID-19 disaster emergency.
20210HB1870PN2119 - 2 -
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30